Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Comera Life Sciences Holdings, Inc. (CMRA : NSDQ)
 
 • Company Description   
Comera Life Sciences Inc. is involved in developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience. Comera Life Sciences Inc., formerly known as OTR Acquisition Corp., is based in WOBURN, Mass.

Number of Employees: 2

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.69 Daily Weekly Monthly
20 Day Moving Average: 8,053,781 shares
Shares Outstanding: 13.24 (millions)
Market Capitalization: $35.62 (millions)
Beta: -0.52
52 Week High: $15.30
52 Week Low: $1.11
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 34.50% 44.46%
12 Week -73.67% -69.10%
Year To Date -73.44% -66.91%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1395 BRICKELL AVENUE SUITE 800
-
MIAMI,FL 33131
USA
ph: 305-697-9600
fax: -
john.woolford@westwicke.com http://www.otracquisition.com
 
 • General Corporate Information   
Officers
Nicholas J. Singer - Chief Executive Officer
Douglas B. Anderson - Chief Financial Officer
Glenn E. Gray - Director
David W. Neithardt - Director
Nadav Besner - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 20037C108
SIC: 6770
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 13.24
Most Recent Split Date: (:1)
Beta: -0.52
Market Capitalization: $35.62 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 7.27
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/22 - -
03/31/22 - -46.92
12/31/21 - -251.75
ROA
06/30/22 - -
03/31/22 - 2.11
12/31/21 - 4.35
Current Ratio
06/30/22 - -
03/31/22 - 0.06
12/31/21 - 1.91
Quick Ratio
06/30/22 - -
03/31/22 - 0.06
12/31/21 - 1.91
Operating Margin
06/30/22 - -
03/31/22 - -
12/31/21 - -
Net Margin
06/30/22 - -
03/31/22 - -
12/31/21 - -
Pre-Tax Margin
06/30/22 - -
03/31/22 - -
12/31/21 - -
Book Value
06/30/22 - -
03/31/22 - -0.52
12/31/21 - -0.69
Inventory Turnover
06/30/22 - -
03/31/22 - -
12/31/21 - -
Debt-to-Equity
06/30/22 - -
03/31/22 - -
12/31/21 - -
Debt-to-Capital
06/30/22 - -
03/31/22 - -
12/31/21 - -
 

Powered by Zacks Investment Research ©